CD95L pro-drug: a novel Swiss Army Knife in cancer therapy?

Kassahn, D; Nachbur, U; Brunner, T (2007). CD95L pro-drug: a novel Swiss Army Knife in cancer therapy? Cell death and differentiation, 14(3), pp. 393-4. Basingstoke: Nature Publishing Group 10.1038/sj.cdd.4402069

Full text not available from this repository. (Request a copy)

Item Type:	Journal Article (Further Contribution)
Division/Institute:	04 Faculty of Medicine > Service Sector > Institute of Pathology
UniBE Contributor:	Brunner, Thomas (A)
ISSN:	1350-9047
ISBN:	17301839
Publisher:	Nature Publishing Group
Language:	English
Submitter:	Factscience Import
Date Deposited:	04 Oct 2013 14:48
Last Modified:	29 Mar 2023 23:32
Publisher DOI:	10.1038/sj.cdd.4402069
PubMed ID:	17301839
Web of Science ID:	000244275400001
URI:	https://boris.unibe.ch/id/eprint/19918 (FactScience: 2995)